Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MBAI Relative to the S&P 500

MBAI Relative to the Sector

Seasonal Chart Analysis

Analysis of the Check-Cap Ltd. (NASD:MBAI) seasonal charts above shows that a Buy Date of December 29 and a Sell Date of April 24 has resulted in a geometric average return of 0.08% above the benchmark rate of the S&P 500 Total Return Index over the past 9 years. This seasonal timeframe has shown positive results compared to the benchmark in 5 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 9 years by an average of 56.23% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

A word of caution: Only 9 years of data is available for shares of MBAI, perhaps insufficient to create a seasonal profile that accurately gauges the seasonal tendencies influencing the investment. Ideally, while 20 years is preferred, at least 10 years of data is required to perform a seasonal analysis that is considered to be reliable for future seasonal periods.

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

To download MBAI seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MBAI